Searched by
Class I
| Clip | Code No. | Product | Data | |||
|---|---|---|---|---|---|---|
| Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
| Sequence | Location (aa) | Storage
temp. |
||||
|
|
||||||
|
TC-0158-4 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLFLGILSV | 188-196 | 4°C | ||||
|
TC-0174-4 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLNEVAKNL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLNEVAKNL | 4°C | |||||
|
TC-0103-4 |
HLA-A*03:01 Influenza NP Tetramer-ILRGSVAHK-BV421 |
|
|||
|
virus | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| ILRGSVAHK | 4°C | |||||
|
TC-0126-4 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-BV421 |
|
|||
|
cancer | BV421 | A*01:01 | 50 tests |
0 (Contact us) |
|
| KSDICTDEY | 243-251 | 4°C | ||||
|
TC-0130-4 |
HLA-A*24:02 HIV env Tetramer-RYLKDQQLL-BV421 |
|
|||
|
virus | BV421 | A*24:02 | 50 tests |
0 (Contact us) |
|
| RYLKDQQLL | 67-75 | 4°C | ||||
|
TS-M538-4 |
H-2Kb VACV B8R Tetramer-TSYKFESV-BV421 |
|
|||
|
virus | BV421 | H-2Kb | 50 tests |
0 (Contact us) |
|
| TSYKFESV | 20-27 | 4°C | ||||
|
TS-M074-2 |
HLA-A*01:01 MAGE-A3 Tetramer-EVDPIGHLY-APC |
|
|||
|
cancer | APC | A*01:01 | 50 tests | 1-9 | |
| EVDPIGHLY | 168-176 | 4°C | ||||
|
TC-5101-2 |
H-2Db MHV S protein Tetramer-CSLWNGPHL-APC |
|
|||
|
virus | APC | H-2Db | 50 tests |
0 (Contact us) |
|
| CSLWNGPHL | 4°C | |||||
|
TS-0014-4C |
HLA-A*02:01 gp100 (Wild) Tetramer-ITDQVPFSV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ITDQVPFSV | 209-217 | 4°C | ||||
|
TS-M051-4 |
HLA-A*02:01 HBV env 335-343 Tetramer-WLSLLVPFV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| WLSLLVPFV | 335-343 | 4°C | ||||
|
TC-5103-4 |
H-2Kb T. gondii tgd057 Tetramer-SVLAFRRL-BV421 |
|
|||
|
Others | BV421 | H-2Kb | 50 tests |
0 (Contact us) |
|
| SVLAFRRL | 4°C | |||||
|
TC-0139-2 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-APC |
|
|||
|
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
|
| CYASGWGSI | 153-161 | 4°C | ||||
|
TC-0170-4 |
HLA-A*02:01 IAPP Tetramer-KLQVFLIVL-BV421 |
|
|||
|
Others | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLQVFLIVL | 5-13 | 4°C | ||||
|
TC-0174-1 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-RLNEVAKNL-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| RLNEVAKNL | 4°C | |||||
|
TS-M017-4 |
HLA-A*02:01 HTLV-1 Tax11-19 Tetramer-LLFGYPVYV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFGYPVYV | 11-19 | 4°C | ||||
|
TS-M037-4 |
HLA-B*35:01 EBV BZLF1 54-64 Tetramer-EPLPQGQLTAY-BV421 |
|
|||
|
virus | BV421 | B*35:01 | 50 tests |
0 (Contact us) |
|
| EPLPQGQLTAY | 54-64 | 4°C | ||||
|
TC-0146-4 |
HLA-A*02:01 EBV LMP1 Tetramer-YLLEMLWRL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLLEMLWRL | 125-133 | 4°C | ||||
|
TC-0149-1 |
HLA-B*35:01 HIV RT Tetramer-VPLDEDFRKY-PE |
|
|||
|
virus | PE | B*35:01 | 50 tests |
0 (Contact us) |
|
| VPLDEDFRKY | 273-282 | 4°C | ||||
|
TC-0149-2 |
HLA-B*35:01 HIV RT Tetramer-VPLDEDFRKY-APC |
|
|||
|
virus | APC | B*35:01 | 50 tests |
0 (Contact us) |
|
| VPLDEDFRKY | 273-282 | 4°C | ||||
|
TC-0165-1 |
HLA-A*02:01 Influenza M1 Tetramer-ILGFVFTLTV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILGFVFTLTV | 4°C | |||||
|
TS-M513-4 |
H-2Db LCMV NP369 Tetramer-FQPQNGQFI-BV421 |
|
|||
|
virus | BV421 | H-2Db | 50 tests |
0 (Contact us) |
|
| FQPQNGQFI | 369-404 | 4°C | ||||
|
TS-5014-2 |
H-2Kb LCMV L protein Tetramer-LEYDFNKL-APC |
|
|||
|
virus | APC | H-2Kb | 50 tests |
0 (Contact us) |
|
| LEYDFNKL | 825-832 | 4°C | ||||
|
TC-0122-1 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLLTRILTI | 4°C | |||||
|
TC-0134-1 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| FVGEFFTDV | 144-152 | 4°C | ||||
|
TC-0151-2 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLQHWVPEL | 97-106 | 4°C | ||||
|
TC-0167-1 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-PE |
|
|||
|
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
|
| RYCNLEGPPI | 177-186 | 4°C | ||||
|
TC-5105-4 |
H-2Kd MAGE-A3 Tetramer-SYVKVLHHM-BV421 |
|
|||
|
cancer | BV421 | H-2Kd | 50 tests |
0 (Contact us) |
|
| SYVKVLHHM | 4°C | |||||
|
TS-M033-4 |
HLA-A*03:01 EBV EBNA3A 603-611 Tetramer-RLRAEAQVK-BV421 |
|
|||
|
virus | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| RLRAEAQVK | 603-611 | 4°C | ||||
|
TC-5104-4 |
H-2Kd Tnpo3 Tetramer-SYMLQALCI-BV421 |
|
|||
|
cancer | BV421 | H-2Kd | 50 tests |
0 (Contact us) |
|
| SYMLQALCI | 4°C | |||||
|
TS-M105-4 |
HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests | 1-9 | |
| SLLMWITQV | 157-165 | 4°C | ||||
|
TC-0129-4 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-BV421 |
|
|||
|
cancer | BV421 | B*35:01 | 50 tests |
0 (Contact us) |
|
| MPFATPMEA | 94-102 | 4°C | ||||
|
TS-M046-4 |
HLA-B*35:01 Influenza NP Tetramer-LPFEKSTVM-BV421 |
|
|||
|
virus | BV421 | B*35:01 | 50 tests |
0 (Contact us) |
|
| LPFEKSTVM | 418-426 | 4°C | ||||
|
TS-0017-4 |
HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLQELNVTV | 169-177 | 4°C | ||||
|
TC-0144-1 |
HLA-B*07:02 H-Y Tetramer-SPSVDKARAEL-PE |
|
|||
|
Others | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| SPSVDKARAEL | 4°C | |||||
|
TC-0159-4 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLPPPGTRV | 149-157 | 4°C | ||||
|
TS-M038-4 |
HLA-B*35:01 EBV LMP2 1-9 Tetramer-MGSLEMVPM-BV421 |
|
|||
|
virus | BV421 | B*35:01 | 50 tests |
0 (Contact us) |
|
| MGSLEMVPM | 1-9 | 4°C | ||||
|
TC-0112-4 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLPLTVAEV | 4°C | |||||
|
TC-0125-1 |
HLA-A*01:01 HCV polyprotein Tetramer-ATDALMTGY-PE |
|
|||
|
virus | PE | A*01:01 | 50 tests |
0 (Contact us) |
|
| ATDALMTGY | 4°C | |||||
|
TC-0155-4 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LTLGEFLKL | 96-104 | 4°C | ||||
|
TC-0105-2 |
HLA-A*03:01 hTERT Tetramer-KLFGVLRLK-APC |
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| KLFGVLRLK | 4°C | |||||
|
TC-0116-1 |
HLA-A*02:01 LCMV GPC 447-455 Tetramer-YLVSIFLHL-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLVSIFLHL | 4°C | |||||
|
TC-0126-1 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-PE |
|
|||
|
cancer | PE | A*01:01 | 50 tests |
0 (Contact us) |
|
| KSDICTDEY | 243-251 | 4°C | ||||
|
TC-0136-1 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | 4°C | ||||
|
TC-0138-1 |
HLA-A*03:01 HIV nef Tetramer-QVPLRPMTYK-PE |
|
|||
|
virus | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| QVPLRPMTYK | 73-82 | 4°C | ||||
|
TS-M055-4 |
HLA-B*35:01 HIV RT Tetramer-NPDIVIYQY-BV421 |
|
|||
|
virus | BV421 | B*35:01 | 50 tests |
0 (Contact us) |
|
| NPDIVIYQY | 175-183 | 4°C | ||||
|
TS-0017-2 |
HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLQELNVTV | 169-177 | 4°C | ||||
|
TS-M040-2 |
HLA-A*02:01 HCV NS3 1406-1415 Tetramer-KLVALGINAV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLVALGINAV | 1406-1415 | 4°C | ||||
|
TC-0158-1 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLFLGILSV | 188-196 | 4°C | ||||
|
TC-0173-4 |
HLA-A*02:01 HPV16 E7 Tetramer-MLDLQPETT-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| MLDLQPETT | 12-20 | 4°C | ||||
|
TS-M120-4 |
HLA-A*02:01 PSA 141-150 Tetramer-FLTPKKLQCV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLTPKKLQCV | 141-150 | 4°C | ||||
|
TS-0017-1 |
HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLQELNVTV | 169-177 | 4°C | ||||
|
TS-0031-2 |
HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPET-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests | 1-9 | |
| YMLDLQPET | 11-19 | 4°C | ||||
|
TC-0166-4 |
HLA-A*03:01 gp100 Tetramer-ALLAVGATK-BV421 |
|
|||
|
cancer | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| ALLAVGATK | 4°C | |||||
|
TS-M039-4 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CINGVCWTV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| CINGVCWTV | 1073-1081 | 4°C | ||||
|
TC-0108-2 |
HLA-A*03:01 Survivin 18-27 (modK) Tetramer-RISTFKNWPK-APC |
|
|||
|
cancer | APC | A*03:01 | 50 tests |
0 (Contact us) |
|
| RISTFKNWPK | 4°C | |||||
|
TC-0125-2 |
HLA-A*01:01 HCV polyprotein Tetramer-ATDALMTGY-APC |
|
|||
|
virus | APC | A*01:01 | 50 tests |
0 (Contact us) |
|
| ATDALMTGY | 4°C | |||||
|
TC-0143-4 |
HLA-B*07:02 HPV E7 Tetramer-KPTLKEYVL-BV421 |
|
|||
|
virus | BV421 | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPTLKEYVL | 5-13 | 4°C | ||||
|
TC-0134-2 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| FVGEFFTDV | 144-152 | 4°C | ||||
|
TS-0012-4C |
HLA-A*02:01 Influenza-M1 Tetramer-GILGFVFTL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GILGFVFTL | 4°C | |||||
|
TC-0109-4 |
HLA-A*03:01 HIV p17 gag Tetramer-RLRPGGKKK-BV421 |
|
|||
|
virus | BV421 | A*03:01 | 50 tests |
0 (Contact us) |
|
| RLRPGGKKK | 4°C | |||||
|
TS-M078-4 |
HLA-A*02:01 MAGE-A10 Tetramer-GLYDGMEHL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLYDGMEHL | 4°C | |||||
|
TC-0161-2 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| VLAGGFFLL | 27-38 | 4°C | ||||
|
TC-0168-2 |
HLA-B*35:01 EBV EBNA1 Tetramer-HPVGEADYFEY-APC |
|
|||
|
virus | APC | B*35:01 | 50 tests |
0 (Contact us) |
|
| HPVGEADYFEY | 4°C | |||||
|
TC-0157-4 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | 4°C | ||||
|
TC-0175-4 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLPDDFTGCV | 4°C | |||||
|
TS-0018-4C |
HLA-A*02:01 HBV core Tetramer-FLPSDFFPSV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLPSDFFPSV | 18-27 | 4°C | ||||
|
TS-0031-4 |
HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPET-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMLDLQPET | 11-19 | 4°C | ||||
|
TC-0109-1 |
HLA-A*03:01 HIV p17 gag Tetramer-RLRPGGKKK-PE |
|
|||
|
virus | PE | A*03:01 | 50 tests |
0 (Contact us) |
|
| RLRPGGKKK | 4°C | |||||
|
TC-0120-1 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLEPGPVTV | 4°C | |||||
|
TC-0128-1 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| ALLTSRLRFI | 615-624 | 4°C | ||||
|
TC-0142-1 |
HLA-B*07:02 HIV gag Tetramer-GPGHKARVL-PE |
|
|||
|
virus | PE | B*07:02 | 50 tests |
0 (Contact us) |
|
| GPGHKARVL | 223-231 | 4°C | ||||
|
TC-0153-4 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLLTVLTVV | 13-21 | 4°C | ||||
|
TC-0164-2 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | 4°C | ||||
|
TC-0114-1 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLQVNSLQTV | 4°C | |||||
|
TC-0120-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLEPGPVTV | 4°C | |||||
|
TC-0131-4 |
HLA-A*02:01 EBV BALF4 Tetramer-FLDKGTYTL-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLDKGTYTL | 276-284 | 4°C | ||||
|
TC-0135-1 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLADQLIHL | 101-109 | 4°C | ||||
|
TC-0156-1 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| QLCPICRAPV | 175-184 | 4°C | ||||
|
TC-0156-4 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| QLCPICRAPV | 175-184 | 4°C | ||||
|
TC-0158-2 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| SLFLGILSV | 188-196 | 4°C | ||||
|
TC-0163-2 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLGSYGFRL | 103-111 | 4°C | ||||
|
TC-0175-2 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLPDDFTGCV | 4°C | |||||
|
TC-0125-4 |
HLA-A*01:01 HCV polyprotein Tetramer-ATDALMTGY-BV421 |
|
|||
|
virus | BV421 | A*01:01 | 50 tests |
0 (Contact us) |
|
| ATDALMTGY | 4°C | |||||
|
TC-0132-4 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| FLYDDNQRV | 828-836 | 4°C | ||||
|
TC-0151-1 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLQHWVPEL | 97-106 | 4°C | ||||
|
TC-0154-2 |
HLA-A*02:01 HHV-8 gB Tetramer-LMWYELSKI-APC |
|
|||
|
virus | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| LMWYELSKI | 4°C | |||||
|
TC-0164-1 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| YMCSFLFNL | 666-674 | 4°C | ||||
|
TS-M115-4 |
HLA-A*02:01 hTERT Tetramer-ILAKFLHWL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| ILAKFLHWL | 4°C | |||||
|
TC-0119-2 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-APC |
|
|||
|
cancer | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| LPWHRLFLL | 208-216 | 4°C | ||||
|
TC-0127-4 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| AILALLPAL | 105-133 | 4°C | ||||
|
TC-0136-4 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| GLAPPQHLIRV | 187-197 | 4°C | ||||
|
TC-0143-2 |
HLA-B*07:02 HPV E7 Tetramer-KPTLKEYVL-APC |
|
|||
|
virus | APC | B*07:02 | 50 tests |
0 (Contact us) |
|
| KPTLKEYVL | 5-13 | 4°C | ||||
|
TC-0173-1 |
HLA-A*02:01 HPV16 E7 Tetramer-MLDLQPETT-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| MLDLQPETT | 12-20 | 4°C | ||||
|
TC-0175-1 |
HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer-KLPDDFTGCV-PE |
|
|||
|
virus | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| KLPDDFTGCV | 4°C | |||||
|
TS-M059-4 |
HLA-A*02:01 AdV 11 Hexon 914-922 Tetramer-LLFEVFDVV-BV421 |
|
|||
|
virus | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| LLFEVFDVV | 914-922 | 4°C | ||||
|
TS-M070-2 |
HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-APC |
|
|||
|
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
|
| KVLEYVIKV | 278-286 | 4°C | ||||
|
TC-0157-1 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| RMPEAAPPV | 65-73 | 4°C | ||||
|
TC-0169-1 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-PE |
|
|||
|
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
|
| GVRGRVEEI | 4°C | |||||
|
TC-0113-4 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| YLFFYRKSV | 4°C | |||||
|
TS-M016-4 |
HLA-A*02:01 WT1126-134 Tetramer-RMFPNAPYL-BV421 |
|
|||
|
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
|
| RMFPNAPYL | 126-134 | 4°C | ||||